Policy / Pricing FDA Achieves Year 1 Goals in Reducing Animal Testing in Drug Development FDASince publishing roadmap last April, agency has successfully launched several key initiatives to replace animal testing with better alternativesPolicy / PricingRead full story pharminent April 20, 2026 (Last updated: April 20, 2026) FDA Since publishing roadmap last April, agency has successfully launched several key initiatives to replace animal testing with better alternatives Policy / PricingRead full story Post navigation Previous: 221: An Interview With Dutch Neurologist Ewout Groen of SMA EuropeNext: Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout Related Stories Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026 Policy / Pricing EU agrees plan to tackle essential medicine shortages pharminent May 12, 2026 Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
